Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53,311,882
-
Total 13F shares
-
3,171,331
-
Share change
-
+410,818
-
Total reported value
-
$18,468,690
-
Price per share
-
$5.83
-
Number of holders
-
40
-
Value change
-
+$2,381,400
-
Number of buys
-
22
-
Number of sells
-
14
Institutional Holders of Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) as of Q1 2018
As of 31 Mar 2018,
Aktis Oncology, Inc. - Common Stock, $0.0001 par value per share (AKTSQ) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,171,331 shares.
The largest 10 holders included
VANGUARD GROUP INC, Herald Investment Management Ltd, BlackRock Inc., Precept Management LLC, Financial Advocates Investment Management, NORTHERN TRUST CORP, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, D.A. DAVIDSON & CO., and UBS Group AG.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.